BioCentury | Sep 26, 2005
Company News

november management update

november AG (FSE:NBX), Erlangen, Germany Business: Supply/Service, Diagnostic Promoted: Astrid Dickert to CFO from director of finance WIR Staff Diagnostic...
BioCentury | Mar 28, 2005
Company News

Epidauros, november sales and marketing update

...acid analysis technology with Epidauros' pharmacogenetics and bioinformatics capabilities. Epidauros Biotechnologie AG , Bernried, Germany november AG...
BioCentury | Jul 26, 2004
Company News

november board of directors update

november AG , Erlangen, Germany Business: Diagnostic, Supply/Service, Gene/Cell therapy Appointed: Agniezka Jankowska, managing partner of Akonsult Departing: Karl Wilhelm Pohl as chairman WIR Staff Diagnostic...
BioCentury | Feb 23, 2004
Company News

november, Zafena AB deal

november AG (NMarkt:NBX), Erlangen, Germany Zafena AB , Linkoping, Sweden Business: Diagnostic Gene therapy and drug delivery company NBX co-founded Zafena to focus on blood banking and the diagnosis and treatment of circulatory disorders and aging....
BioCentury | Nov 10, 2003
Company News

november, Siemens deal

...viruses and cancer. The companies plan to launch the system by the end of 2004. november AG...
BioCentury | Jun 16, 2003
Company News

Avontec management update

...GmbH , Martinsried, Germany Business: Cardiovascular, Autoimmune/Inflammation Hired: Thomas Schulze as CEO, formerly COO of november AG...
BioCentury | May 12, 2003
Company News

november management update

november AG , Erlangen, Germany Business: Diagnostics/Imaging, Supply/Service, Gene/Cell therapy Hired: Alexander Offer as head of finance, formerly VP of an independent German investment bank; he replaces Hans-Dieter Tresser WIR Staff...
BioCentury | Mar 3, 2003
Company News

november diagnostics/imaging, drug delivery, gene/cell therapy news

...profits. NBX said the move will facilitate fundraising and its ability to establish collaborative partnerships. november AG...
BioCentury | Mar 3, 2003
Company News

november management update

november AG , Erlangen, Germany Business: Diagnostics/Imaging, Supply/Service, Gene/Cell therapy Resigned: Hans-Dieter Tresser as CFO WIR Staff...
BioCentury | Jul 1, 2002
Finance

Europe: Less of a cash crunch

...valued at £71 million ($106 million) (off 16%); and gene therapy and drug delivery company november AG...
Items per page:
1 - 10 of 26
BioCentury | Sep 26, 2005
Company News

november management update

november AG (FSE:NBX), Erlangen, Germany Business: Supply/Service, Diagnostic Promoted: Astrid Dickert to CFO from director of finance WIR Staff Diagnostic...
BioCentury | Mar 28, 2005
Company News

Epidauros, november sales and marketing update

...acid analysis technology with Epidauros' pharmacogenetics and bioinformatics capabilities. Epidauros Biotechnologie AG , Bernried, Germany november AG...
BioCentury | Jul 26, 2004
Company News

november board of directors update

november AG , Erlangen, Germany Business: Diagnostic, Supply/Service, Gene/Cell therapy Appointed: Agniezka Jankowska, managing partner of Akonsult Departing: Karl Wilhelm Pohl as chairman WIR Staff Diagnostic...
BioCentury | Feb 23, 2004
Company News

november, Zafena AB deal

november AG (NMarkt:NBX), Erlangen, Germany Zafena AB , Linkoping, Sweden Business: Diagnostic Gene therapy and drug delivery company NBX co-founded Zafena to focus on blood banking and the diagnosis and treatment of circulatory disorders and aging....
BioCentury | Nov 10, 2003
Company News

november, Siemens deal

...viruses and cancer. The companies plan to launch the system by the end of 2004. november AG...
BioCentury | Jun 16, 2003
Company News

Avontec management update

...GmbH , Martinsried, Germany Business: Cardiovascular, Autoimmune/Inflammation Hired: Thomas Schulze as CEO, formerly COO of november AG...
BioCentury | May 12, 2003
Company News

november management update

november AG , Erlangen, Germany Business: Diagnostics/Imaging, Supply/Service, Gene/Cell therapy Hired: Alexander Offer as head of finance, formerly VP of an independent German investment bank; he replaces Hans-Dieter Tresser WIR Staff...
BioCentury | Mar 3, 2003
Company News

november diagnostics/imaging, drug delivery, gene/cell therapy news

...profits. NBX said the move will facilitate fundraising and its ability to establish collaborative partnerships. november AG...
BioCentury | Mar 3, 2003
Company News

november management update

november AG , Erlangen, Germany Business: Diagnostics/Imaging, Supply/Service, Gene/Cell therapy Resigned: Hans-Dieter Tresser as CFO WIR Staff...
BioCentury | Jul 1, 2002
Finance

Europe: Less of a cash crunch

...valued at £71 million ($106 million) (off 16%); and gene therapy and drug delivery company november AG...
Items per page:
1 - 10 of 26